Thought Leader Select, a Chapel Hill, North Carolina-based research and consulting firm for the biopharmaceutical and healthcare industries, announces the commencement a research assessment of key opinion leaders and centers of excellence in the treatment area of women’s health. The company will perform the assessment for a top-50 global biopharmaceutical firm entering the treatment of conditions affecting women.
For the assessment, Thought Leader Select will use its proprietary KOL identification and profiling methodology, known as deep profiling, to pinpoint 100 U. S. key opinion leaders in women’s health, with specialty in the area of obstetrics and gynecology. The company will then study the skills and experience of American OB/GYNs in several areas of thought leadership in the medical field, including areas of expertise, leadership in basic and clinical research, and research publishing in leading scientific journals.
The client company will utilize Thought Leader Select’s findings to engage key opinion leaders in obstetrics and gynecology on a number of fronts, including advisory boards, consulting, and medical science liaison outreach.
In addition to assessing OB/GYN KOLs in the United States, Thought Leader Select will also apply its objective, validated methodology to identify and profile 50 American centers of excellence in the area of women’s health. For the centers of excellence assessment, Thought Leader Select will gauge each center’s community footprint of associated physicians and clinics, residency and fellowship programs, as well as its cumulative experience in areas like basic and clinical research and publishing in leading scientific journals.
The company will utilize Thought Leader Selects findings to engage physicians and researchers at each center to advance treatments in women’s health.
“Thought Leader Select is thrilled to be collaborating with a great company as they bring new medicines to the area of women’s health,” stated Neil Mellor, Thought Leader Select’s global business development consultant. “We have been privileged to work in women’s health many times in areas like breast, ovarian, and cervical cancer, and this latest opportunity solidifies our reputation as the research and consulting company most-equipped to help biopharmaceutical companies advance new medicines to improve quality of life for women everywhere.”
About Neil Mellor
Neil Mellor is a global business development consultant at Thought Leader Select. Exemplifying Thought Leader Select’s commitment to subject matter expertise, Neil brings over two decades of experience in leading sales, marketing, and public relations for global biopharmaceutical companies such as Merck, GlaxoSmithKline, and Pfizer. Throughout his career, Neil has spearheaded key opinion leader outreach programs in North America and Europe, in addition to his consulting work with companies entering markets across the globe.
About Thought Leader Select
Thought Leader Select serves the biopharmaceutical and healthcare industries, as well as the medical community at large by assessing medical experts (known as “thought leaders” and “key opinion leaders”) within a host of therapeutic areas such as diabetes, oncology, and neurology.
Over two dozen of the top 50 global biopharmaceutical and healthcare companies count on our expertise when seeking to launch new medications for better public health, ensuring that they are collaborating with the right medical professionals for the right reasons—their skills and experiences.
